Jamie L. Eberling

Safety and tolerability of putaminal <i>AADC</i> gene therapy for Parkinson disease

Chadwick W. Christine, Philip A. Starr, Paul Larson et al. · Neurology · 2009 · 431 citations · Full text

Medicine, Neurology, Pharmacology +17

Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach

Krys S. Bankiewicz, Jamie L. Eberling, Małgorzata Kohutnicka et al. · Experimental Neurology · 2000 · 410 citations

Pharmacy, Neuroscience, Pharmaceutics +16

Results from a phase I safety trial of <i>hAADC</i> gene therapy for Parkinson disease

Jamie L. Eberling, William J. Jagust, Chadwick W. Christine et al. · Neurology · 2008 · 367 citations

Medicine, Neurology, Neuroscience +17

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia et al. · Movement Disorders · 2015 · 307 citations · Full text

Medicine, Neurology, Psychiatry +17

Long-Term Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV-hAADC

Krystof S. Bankiewicz, John Forsayeth, Jamie L. Eberling et al. · Molecular Therapy · 2006 · 279 citations · Full text

Life Sciences, Neurology, Neuroscience +17